Clinical Trial Update: Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain [Phase 2]

View source ↗

Summary

This update announces a Phase 2 clinical trial evaluating Halneuron for chemotherapy-induced neuropathic pain, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neuropathic Pain

Drugs mentioned

• Halneuron

Snippet

Sponsor: Dogwood Therapeutics Inc. | Conditions: Chemotherapy Induced Neuropathic Pain | Phase 2 | Status: RECRUITING